Andrew Vahabzadeh-Hagh, MD
Otolaryngology · San Diego, CANPI 1346506920
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Aerin Medical Inc. accounts for 77.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $2,715, 9.4 times the $288 reported in 2019.
Across 32 payments — averaging $132.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$3K
- Inspire Medical Systems, Inc.$195
- Merz North America, Inc.$166
- Stryker$149
- Amgen$116
- Integra Lifesciences Corporation$86
- plus $232 from 4 others
What the payments were for
- Consulting fees$1,50035%
- Travel & lodging$1,37432%
- Food & beverage$1,35432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 14 | $3,284 |
| Inspire Medical Systems, Inc. | 2 | $195 |
| Merz North America, Inc. | 1 | $166 |
| Stryker | 2 | $149 |
| Amgen | 1 | $116 |
| Integra Lifesciences Corporation | 4 | $86 |
| Kls-martin L.p. | 3 | $74 |
| Tactile Systems Technology Inc | 1 | $65 |
| Johnson & Johnson | 3 | $60 |
| Neurent Medical Limited | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$2,883
- RHINAER STYLUS$488
- Inspire Upper Airway Stimulation System$174
- XEOMIN$166
- AIMOVIG$116
- 1588 HD 3 CHIP CAMERA$113
How this compares
$4,228 in reported general payments places this provider in the 80th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 201 | $2,714 |
| Ipratropium Bromide | 36 | $884 |
| Omeprazole | 22 | $497 |
| Fluticasone Propionate | 40 | $370 |
| Amitriptyline Hcl | 17 | $152 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in San Diego
- Brian WeeksSan Diego$924K
- Adam DecondeSan Diego$32K
- Theresa GuoSan Diego$24K
- Charles TesarSan Diego$21K
- Charles CoffeySan Diego$20K
- Erik ViirreSan Diego$17K
- Jo-Lawrence BigcasSan Diego$15K
- Randall OwRoseville$613K
- Amir MoradiVista$389K
- Keith BlackwellLos Angeles$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.